skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 43,769  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Kaplan-Meier Survival Analysis: Practical Insights for Clinicians
Material Type:
Article
Add to My Research

Kaplan-Meier Survival Analysis: Practical Insights for Clinicians

Acta médica portuguesa, 2024-04, Vol.37 (4)

ISSN: 0870-399X ;EISSN: 1646-0758 ;DOI: 10.20344/amp.21080

Full text available

2
Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized Trial
Material Type:
Article
Add to My Research

Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized Trial

Journal of clinical oncology, 2020-09, Vol.38 (25), p.2830-2838 [Peer Reviewed Journal]

2020 by American Society of Clinical Oncology 2020 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/jco.20.00818 ;PMID: 32484754

Full text available

3
An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics
Material Type:
Article
Add to My Research

An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics

Cell, 2018-04, Vol.173 (2), p.400-416.e11 [Peer Reviewed Journal]

2018 Elsevier Inc. ;Copyright © 2018 Elsevier Inc. All rights reserved. ;ISSN: 0092-8674 ;EISSN: 1097-4172 ;DOI: 10.1016/j.cell.2018.02.052 ;PMID: 29625055

Full text available

4
Nonparametric survival analysis using Bayesian Additive Regression Trees (BART)
Material Type:
Article
Add to My Research

Nonparametric survival analysis using Bayesian Additive Regression Trees (BART)

Statistics in medicine, 2016-07, Vol.35 (16), p.2741-2753 [Peer Reviewed Journal]

Copyright © 2016 John Wiley & Sons, Ltd. ;Copyright Wiley Subscription Services, Inc. Jul 20, 2016 ;ISSN: 0277-6715 ;EISSN: 1097-0258 ;DOI: 10.1002/sim.6893 ;PMID: 26854022 ;CODEN: SMEDDA

Full text available

5
Comprehensive genomic analysis identifies novel subtypes and targets of triple-negative breast cancer
Material Type:
Article
Add to My Research

Comprehensive genomic analysis identifies novel subtypes and targets of triple-negative breast cancer

Clinical cancer research, 2015-04, Vol.21 (7), p.1688-1698 [Peer Reviewed Journal]

2014 American Association for Cancer Research. ;ISSN: 1078-0432 ;EISSN: 1557-3265 ;DOI: 10.1158/1078-0432.ccr-14-0432 ;PMID: 25208879

Full text available

6
Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS Trial
Material Type:
Article
Add to My Research

Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS Trial

Journal of clinical oncology, 2021-06, Vol.39 (18), p.1995-2004 [Peer Reviewed Journal]

ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.20.03614 ;PMID: 33891478

Full text available

7
QuPath: Open source software for digital pathology image analysis
Material Type:
Article
Add to My Research

QuPath: Open source software for digital pathology image analysis

Scientific reports, 2017-12, Vol.7 (1), p.16878-7, Article 16878 [Peer Reviewed Journal]

2017. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2017 ;ISSN: 2045-2322 ;EISSN: 2045-2322 ;DOI: 10.1038/s41598-017-17204-5 ;PMID: 29203879

Full text available

8
UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses
Material Type:
Article
Add to My Research

UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses

Neoplasia (New York, N.Y.), 2017-08, Vol.19 (8), p.649-658 [Peer Reviewed Journal]

2017 The Authors ;Copyright © 2017 The Authors. Published by Elsevier Inc. All rights reserved. ;Copyright Neoplasia Press Aug 2017 ;ISSN: 1476-5586 ;ISSN: 1522-8002 ;EISSN: 1476-5586 ;DOI: 10.1016/j.neo.2017.05.002 ;PMID: 28732212

Full text available

9
Dexamethasone in Hospitalized Patients with Covid-19
Material Type:
Article
Add to My Research

Dexamethasone in Hospitalized Patients with Covid-19

New England Journal of Medicine, 2021-02, Vol.384 (8), p.693-704 [Peer Reviewed Journal]

Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;Copyright © 2020 Massachusetts Medical Society. ;COPYRIGHT 2021 Massachusetts Medical Society ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2021436 ;PMID: 32678530

Digital Resources/Online E-Resources

10
Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial
Material Type:
Article
Add to My Research

Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial

The Lancet (British edition), 2008-09, Vol.372 (9644), p.1174-1183 [Peer Reviewed Journal]

Elsevier Ltd ;2008 Elsevier Ltd ;Copyright Elsevier Limited Sep 27-Oct 3, 2008 ;ISSN: 0140-6736 ;ISSN: 1474-547X ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(08)61242-8 ;PMID: 18757085 ;CODEN: LANCAO

Full text available

11
Nivolumab Versus Docetaxel in Previously Treated Patients With Advanced Non-Small-Cell Lung Cancer: Two-Year Outcomes From Two Randomized, Open-Label, Phase III Trials (CheckMate 017 and CheckMate 057)
Material Type:
Article
Add to My Research

Nivolumab Versus Docetaxel in Previously Treated Patients With Advanced Non-Small-Cell Lung Cancer: Two-Year Outcomes From Two Randomized, Open-Label, Phase III Trials (CheckMate 017 and CheckMate 057)

Journal of clinical oncology, 2017-12, Vol.35 (35), p.3924-3933 [Peer Reviewed Journal]

2017 by American Society of Clinical Oncology 2017 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2017.74.3062 ;PMID: 29023213

Full text available

12
BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting
Material Type:
Article
Add to My Research

BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting

The New England journal of medicine, 2021-04, Vol.384 (15), p.1412-1423 [Peer Reviewed Journal]

Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;Copyright © 2021 Massachusetts Medical Society. ;COPYRIGHT 2021 Massachusetts Medical Society ;Copyright © 2021 Massachusetts Medical Society. All rights reserved. 2021 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2101765 ;PMID: 33626250

Full text available

13
Predicting Survival in Patients With Pulmonary Arterial Hypertension: The REVEAL Risk Score Calculator 2.0 and Comparison With ESC/ERS-Based Risk Assessment Strategies
Material Type:
Article
Add to My Research

Predicting Survival in Patients With Pulmonary Arterial Hypertension: The REVEAL Risk Score Calculator 2.0 and Comparison With ESC/ERS-Based Risk Assessment Strategies

Chest, 2019-08, Vol.156 (2), p.323-337 [Peer Reviewed Journal]

Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved. ;EISSN: 1931-3543 ;DOI: 10.1016/j.chest.2019.02.004 ;PMID: 30772387

Full text available

14
Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results
Material Type:
Article
Add to My Research

Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results

New England Journal of Medicine, 2021-02, Vol.384 (6), p.497-511 [Peer Reviewed Journal]

Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;Copyright © 2020 Massachusetts Medical Society. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Distributed under a Creative Commons Attribution 4.0 International License ;Copyright © 2020 Massachusetts Medical Society. All rights reserved. 2020 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2023184 ;PMID: 33264556

Digital Resources/Online E-Resources

15
Cryoballoon or Radiofrequency Ablation for Paroxysmal Atrial Fibrillation
Material Type:
Article
Add to My Research

Cryoballoon or Radiofrequency Ablation for Paroxysmal Atrial Fibrillation

The New England journal of medicine, 2016-06, Vol.374 (23), p.2235-2245 [Peer Reviewed Journal]

Copyright © 2016 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1602014 ;PMID: 27042964

Full text available

16
A Fully Magnetically Levitated Left Ventricular Assist Device — Final Report
Material Type:
Article
Add to My Research

A Fully Magnetically Levitated Left Ventricular Assist Device — Final Report

The New England journal of medicine, 2019-04, Vol.380 (17), p.1618-1627 [Peer Reviewed Journal]

Copyright © 2019 Massachusetts Medical Society. All rights reserved. ;Copyright © 2019 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1900486 ;PMID: 30883052

Full text available

17
ARCHES: A Randomized, Phase III Study of Androgen Deprivation Therapy With Enzalutamide or Placebo in Men With Metastatic Hormone-Sensitive Prostate Cancer
Material Type:
Article
Add to My Research

ARCHES: A Randomized, Phase III Study of Androgen Deprivation Therapy With Enzalutamide or Placebo in Men With Metastatic Hormone-Sensitive Prostate Cancer

Journal of clinical oncology, 2019-11, Vol.37 (32), p.2974-2986 [Peer Reviewed Journal]

2019 by American Society of Clinical Oncology 2019 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.19.00799 ;PMID: 31329516

Full text available

18
Venetoclax plus LDAC for newly diagnosed AML ineligible for intensive chemotherapy: a phase 3 randomized placebo-controlled trial
Material Type:
Article
Add to My Research

Venetoclax plus LDAC for newly diagnosed AML ineligible for intensive chemotherapy: a phase 3 randomized placebo-controlled trial

Blood, 2020-06, Vol.135 (24), p.2137-2145 [Peer Reviewed Journal]

2020 American Society of Hematology ;2020 by The American Society of Hematology. ;2020 by The American Society of Hematology 2020 ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood.2020004856 ;PMID: 32219442

Full text available

19
The single-cell pathology landscape of breast cancer
Material Type:
Article
Add to My Research

The single-cell pathology landscape of breast cancer

Nature (London), 2020-02, Vol.578 (7796), p.615-620 [Peer Reviewed Journal]

COPYRIGHT 2020 Nature Publishing Group ;COPYRIGHT 2020 Nature Publishing Group ;Copyright Nature Publishing Group Feb 27, 2020 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-019-1876-x ;PMID: 31959985

Full text available

20
Accelerated Partial-Breast Irradiation Compared With Whole-Breast Irradiation for Early Breast Cancer: Long-Term Results of the Randomized Phase III APBI-IMRT-Florence Trial
Material Type:
Article
Add to My Research

Accelerated Partial-Breast Irradiation Compared With Whole-Breast Irradiation for Early Breast Cancer: Long-Term Results of the Randomized Phase III APBI-IMRT-Florence Trial

Journal of clinical oncology, 2020-12, Vol.38 (35), p.4175-4183 [Peer Reviewed Journal]

ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.20.00650 ;PMID: 32840419

Full text available

Results 1 - 20 of 43,769  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (39,739)

Refine My Results

Creation Date 

From To
  1. Before 1992  (9)
  2. 1992 To 1998  (14)
  3. 1999 To 2006  (217)
  4. 2007 To 2014  (22,271)
  5. After 2014  (21,259)
  6. More options open sub menu

Subject 

  1. Kaplan-Meier Estimate  (43,711)
  2. Humans  (42,859)
  3. Science & Technology  (41,536)
  4. Life Sciences & Biomedicine  (39,056)
  5. Female  (37,746)
  6. Male  (34,299)
  7. Middle Aged  (32,195)
  8. Aged  (28,355)
  9. Adult  (21,274)
  10. Prognosis  (16,892)
  11. Oncology  (15,015)
  12. Treatment Outcome  (14,736)
  13. Proportional Hazards Models  (13,751)
  14. Retrospective Studies  (13,697)
  15. Aged, 80 And Over  (12,177)
  16. Risk Factors  (11,582)
  17. Time Factors  (8,917)
  18. Disease-Free Survival  (8,835)
  19. Biological And Medical Sciences  (7,088)
  20. Surgery  (7,041)
  21. More options open sub menu

Language 

  1. English  (43,539)
  2. Japanese  (7,802)
  3. Portuguese  (294)
  4. Spanish  (144)
  5. Russian  (60)
  6. Chinese  (57)
  7. German  (37)
  8. Norwegian  (29)
  9. French  (26)
  10. Icelandic  (13)
  11. Polish  (11)
  12. Turkish  (10)
  13. Czech  (9)
  14. Korean  (7)
  15. Lithuanian  (4)
  16. Italian  (2)
  17. Hungarian  (1)
  18. Romanian  (1)
  19. Croatian  (1)
  20. Swedish  (1)
  21. More options open sub menu

Searching Remote Databases, Please Wait